Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 9,389

Document Document Title
WO/2014/183555A1
The present invention relates to a cycloalkyl acid derivative, a preparation method thereof, and a pharmaceutical application thereof, and in particular, the present invention relates to a cycloalkyl acid derivative represented by genera...  
WO/2014/180238A1
The present invention discloses an antihypoxic pharmaceutical composition and application thereof. The pharmaceutical composition contains vinpocetine and L-carnitine or a derivative thereof and a pharmaceutically acceptable salt thereof...  
WO/2014/180248A1
The present invention relates to an oral pharmaceutical composition for increasing hypoxia tolerance, characterized in that the pharmaceutical composition comprises active ingredient L-carnitine or derivative thereof or pharmaceutically ...  
WO/2014/180239A1
The present invention provides a pharmaceutical composition used for treating severe altitude sickness, characterized by a composition consisting of trimetazidine or pharmaceutically acceptable salt thereof and L-carnitine or derivative ...  
WO/2014/180240A1
The present invention discloses a slow-release agent for increasing hypoxia tolerance; the slow-release agent is a composition formed by combining trimetazidine or pharmaceutically acceptable salt thereof and L-carnitine or derivative th...  
WO/2014/175180A1
A quercetin glycoside and a fructooligosaccharide in a ratio (by weight) of 1 to at least 0.1 are incorporated to produce a quercetin glycoside-containing oral composition and to mitigate the bitterness of the quercetin glycoside contain...  
WO/2014/173174A1
The present invention describes a reduction type coenzyme Q10 powder, a composition thereof, and a preparation method thereof. The reduction type coenzyme Q10 powder is obtained by reacting an oxidation type coenzyme Q10 with the presenc...  
WO/2014/170801A1
According to the invention, a thermus thermophilus fermentation medium (INCI name "Thermus thermophilus Ferment" marketed by Sederma under the trade name VENUCEANE™) is used to prevent and/or treat damages associated with infrared radi...  
WO/2014/169542A1
Disclosed is a veterinary drug composition for preventing and treating mycotoxin poisoning, and a formulation and preparation method thereof. The veterinary drug composition for preventing and treating mycotoxin poisoning is prepared fro...  
WO/2014/171854A1
The invention relates to the pharmaceutical industry and to the field of medicine. The problem addressed by the present invention is the creation of an effective antioxidant pharmaceutical composition. The problem is solved in that an an...  
WO/2014/168523A1
The present invention relates to novel biologically active compounds being dicarboxylic acid bisamide derivatives of general formula (I), or pharmaceutically acceptable salts thereof, which are capable of complexing or chelating metal io...  
WO/2014/154131A1
Provided are a caffeoyl substituted pentacyclic triterpene derivative as represented by formula (I) and pharmaceutical composition containing the same. Also provided are uses of the derivative in the preparation of drugs or health-care p...  
WO/2014/154927A1
The invention relates to the use of the inhibitor of the activity of the steroid sulfatase enzyme STX64 for treating aging, and thus for increasing the longevity of individuals or improving their quality of life. The invention also relat...  
WO/2014/148422A1
An extraction composition produced from licorice (scientific name: Glycyrrhiza), which is characterized by containing glycyrrhetinic acid and a salt thereof (an extraction component (A)) in an amount of 0.5 to 20 wt% relative to the weig...  
WO/2014/150413A1
Described herein is a new antidote for the rapid elimination of carbon monoxide from hemoglobin, including brain, heart, and red cell hemoglobin. The disclosed therapy involves the use of modified human globins, particularly neuroglobins...  
WO/2014/146044A1
Disclosed are methods and compositions related to methods of treating, ameliorating, mitigating, slowing, arresting, preventing or reversing various diseases and conditions, including age-related obesity, age-related increases in blood l...  
WO/2014/138920A1
The present invention relates to a method for extracting shrimp oil. Particularly, shrimp processing water (EPC) is recovered and subjected to a dissolved air flotation (DAF) system after adding a flocculating agent. The suspended and di...  
WO/2014/136079A1
Orally administerable deferasirox formulations are disclosed having reduced release under gastric conditions and fast release at near neutral pH or at neutral pH.  
WO/2014/136944A1
The present invention addresses the problem of providing an aqueous liquid composition which is suitable for oral ingestion and includes a high concentration of histidine, a method for preparing the liquid composition, and uses, and the ...  
WO/2014/129614A1
The purpose of the present invention is to provide an orally administered adsorbent capable of adsorbing large quantities of tryptophan or indoxyl sulfate in the presence of bile acid. Accordingly, an orally administered adsorbent is cha...  
WO/2014/127475A1
A composition for the treatment of perianal disorders. In particular, the composition includes three components: a) an analgesic, b) a cryoprotective agent and c) a muscle relaxant.  
WO/2014/129618A1
The purpose of the present invention is to provide surface-modified spherical active carbon exhibiting excellent adsorption capacity with respect to uremic substances in the body, and particularly with respect to β-aminoisobutyric acid....  
WO/2014/129617A1
The purpose of the present invention is to provide spherical active carbon exhibiting excellent adsorption capacity with respect to uremic substances in the body, and particularly with respect to β-aminoisobutyric acid. Accordingly, pro...  
WO/2014/129616A1
The purpose of the present invention is to provide an orally administered adsorbent capable of adsorbing large quantities of tryptophan or indoxyl sulfate in the presence of bile acid. Accordingly, an orally administered adsorbent is cha...  
WO/2014/126596A1
The neuroprotective multifunctional antioxidants are compounds that contain a 2-diacetylamino-5-hydroxypyrimidine moiety, having the structural formula: wherein R1 is CH2 or C2H4; R2 is H or -OR4 where R4 is H or aryl; and R3a and R3b ar...  
WO/2014/124140A1
Methods, compositions and kits for the prevention and treatment of mitochondrial dysfunction, mitochondrial DNA damage and genomic DNA damage are provided. The methods use the administration of palm fruit juice and/or compositions contai...  
WO/2014/116723A1
This disclosure provides compositions, kits, and methods useful for treating or preventing viral and bacterial infection and reducing or preventing the effects of toxins. The methods comprise administering to a subject an effective amoun...  
WO/2014/116591A3
The present disclosure provides methods of preventing activation of neutrophils with mitochondrially targeted antioxidants.. Also disclosed are methods of preventing or treating different inflammatory diseases and inflammation-related co...  
WO/2014/114254A1
Disclosed in the present invention is new use of saturated amine compounds for use in preparing medicines to resist radiation damage and promoting regeneration and repair of radiation-damaged tissues. Experiments show that the saturated ...  
WO/2014/111957A1
The present invention relates to nitric oxide releasing prodrugs of known drugs or therapeutic agents wherein the drug or therapeutic agents contain at least one carboxylic acid group. The invention also relates to processes for the prep...  
WO/2014/113609A1
Stable indole-3-propionic acid salts of S-adenosyl-L-methionine, or a pharmaceutically acceptable salt thereof, are disclosed, as well as pharmaceutical compositions comprising the indole-3-propionic acid salts, methods of using the indo...  
WO/2014/112573A1
A fucoxanthin-containing composition containing: (A) fucoxanthin; (B) one or more emulsifiers selected from the group consisting of a glycerin fatty-acid ester, a polyglycerin fatty-acid ester, a sucrose fatty-acid ester, and lecithin; a...  
WO/2014/110277A1
The invention relates to the use of scyllo-inositol in treating personality disorders, in particular social withdrawal, as well as pharmaceutical compositions comprising effective amounts of scyllo-inositol for treating such disorders.  
WO/2014/110551A1
The present invention relates to antioxidant flavonoids, compositions containing such antioxidant flavonoids and methods for using such antioxidant flavonoids to treat, e.g., AMD.  
WO/2014/106473A1
Disclosed is use of glycyrrhetinic acid or glycyrrhizic acid in preventing or treating radiation injury of soft tissue. Therefore, glycyrrhetinic acid or glycyrrhizic acid can be used for preparing medicaments for preventing or treating ...  
WO/2014/103475A1
The purpose of the present invention is to provide a skin-exterior anti-ageing composition for preventing or improving trouble areas upon the exterior of the skin caused by ageing and degradation such as wrinkles, fine lines, blotches, a...  
WO/2014/104171A1
The purpose of the present invention is to provide a skin-exterior anti-ageing composition for preventing or improving trouble areas upon the exterior of the skin caused by ageing and degradation such as wrinkles, fine lines, blotches, a...  
WO/2014/100901A1
The invention is directed to a method of producing a peptide having antioxidant activity from barley hordein by treating barley hordein with alcalase at a sufficient time and temperature suitable for hydrolysis; and recovering the peptid...  
WO/2014/101366A1
The present invention relates to methods of treating one or more symptoms of a SHC-1/p66-related disease, inhibiting ROS generation or for the manufacture of a medicament in the above-mentioned treatment.  
WO/2014/104157A1
Provided is a method for simply producing a polyphenol composition which has excellent solubility in water and is in a solid state. A method for producing a polyphenol composition, which comprises the following steps (1) and (2). (1) a s...  
WO/2014/102692A1
The invention provides a composition comprising Lactobacillus fermentum ME-3 strain DSM 14241 for use in preventing, alleviating the symptoms of or treating, alone or as an adjuvant component,a metabolic syndrome related disorder selecte...  
WO/2014/100834A1
A composition and method for treating excess cyanide and hydrogen sulfide comprising administering a cobinamide. Further a method for determining extent of binding by an agent to an extracellular matrix.  
WO/2014/097284A1
This invention refers to a series of substances according to formula (I): and its synthesis process. The subtances according to formula I above, known as sulphated chelating agents have the ability to enlarge/loosen simple cell membranes...  
WO/2014/100088A1
The present invention is directed to concentrated liquid human milk fortifiers using extensively hydrolyzed casein as a protein source, a stabilizer system comprising octenyl succinic anhydride modified corn starch in combination with a ...  
WO/2014/096488A1
The invention relates to phenolic extracts containing procyanidins, propelargonidins and flavonolignans, that have properties/activities that are potentially beneficial for human health, and are obtained from the aerial parts and the inn...  
WO/2014/098092A1
Provided is a prophylactic/therapeutic agent for dry eye, which comprises a novel component capable of preventing the deterioration of a tear fluid secretion ability and also capable of inhibiting the generation of active oxygen in tear ...  
WO/2014/096437A1
The present invention relates to a nucleic acid molecule encoding a polypeptide, the polypeptide having the activity of alternative oxidase (AOX), wherein said nucleic acid molecule is selected from the group consisting of (a) a nucleic ...  
WO/2014/090183A1
Provided is a milk-derived biologically active polypeptide having an amino acid sequence of LPLP, which has in-vitro antioxidation activity and enhances immunity of human body. The polypeptide has good biological antioxidation activity, ...  
WO/2014/090180A1
Provided is a milk-derived biologically active polypeptide having an amino acid sequence of QEPV, which has in-vitro antioxidation activity and enhances immunity of human body. The polypeptide has good biological antioxidation activity, ...  
WO/2014/090184A1
Provided is a milk-derived biologically active polypeptide having an amino acid sequence of QEPVL, which has in-vitro antioxidation activity and promotes immune activity of human body. In-vitro antioxidation and in-vitro immunity promoti...  

Matches 1 - 50 out of 9,389